Inflammatory myofibroblastic tumors are benign neoplasms histologically composed of lymphocytes, histiocytes, macrophages, foam cells, and plasma cells among a spindle-shaped stroma. Their etiology and potential for metastatic spread is controversial. Numerous predisposing factors have been suggested, including preceding infections, radiotherapy, and local trauma. We present two cases of pseudotumors that developed in children following hematopoietic stem cell transplantation. These are the first cases after hematopoietic transplant reported in the literature. As these neoplasms are difficult to diagnose and are often confused with highly aggressive tumors, our cases demonstrate that a high index of suspicion for such lesions must be maintained when evaluating masses in post transplant patients.
tumor; children Inflammatory pseudotumor, also known as inflammatory myofibroblastic tumor (IMT), is a tumor-like mass pathologically composed of lymphocytes, plasma cells, histiocytes, macrophages, and foam cells within a benign appearing spindle-shaped stroma. [1] [2] [3] Typically, it is a tumor that is seen in children and young adults. Most commonly, it has been described in the lung and mediastinum, but it has also been identified in numerous locations throughout the body including the abdomen, the retroperitoneum, pelvis, and extremities. 1, 3, 4 Pseudotumors have been found in association with constitutional symptoms including fever, growth failure, weight loss, and malaise, as well as laboratory abnormalities including anemia, leukocytosis, thrombocytosis, elevated sedimentation rate, and polyclonal hypergammaglobulinemia. 1, [3] [4] [5] An exact etiology remains unclear; however, a pre-existing infection has been proposed as one possible contributing factor. Hepatitis C, EBV, HIV, bacterial, fungal, and TB infections prior to the development of pseudotumors have been documented. [2] [3] [4] Others have postulated that pseudotumors result from a response to noninfectious insults such as trauma, surgery, and previous radiotherapy. 1, 2 Conflicting reports also exist as to these tumors' malignant potential. Historically, the lesions have been considered nonmalignant. This distinction was based on observations that pseudotumors typically do not metastasize and are treated with simple surgical excision. Recurrence is fairly common; however, repeat surgical excision is usually curative.
1,2 Recently, Coffin et al have emphasized the use of the term 'inflammatory myofibroblastic tumor' as opposed to 'inflammatory pseudotumor'. These authors suggest that the lesions should be considered of indeterminate or low malignant potential and emphasize their neoplastic rather than inflammatory nature. In their review, they highlight the preponderance of local recurrence, cases of multifocal disease, and the common pathological documentation of local and vascular invasion. 1, 3 Pseudotumors have also been described in association with Wilm's tumor, chronic sclerosing cholangitis, acute myelogenous leukemia, Hodgkin's disease, small cell carcinoma of the lung, adrenal cortical carcinoma, gastric carcinoma, and renal cell carcinoma. 1, 3, 6 There are very rare case reports of distant metastases. 7 A recent retrospective review identified 147 malignancies developing after stem cell transplant among a study group of over 3000 children and adults. Pseudotumors were not reported among this group of patients. 8 We describe two cases of pseudotumors developing in pediatric patients after hematopoietic stem cell transplantation. One patient underwent an allogeneic, matched sibling donor transplant for acute leukemia, while the second patient received an autologous peripheral blood stem cell transplant for Stage IV neuroblastoma. Both patients received total body irradiation (TBI) in preparation for transplant. These two cases suggest additional predisposing factors for IMTs and support the recent implication of radiation as one possible underlying cause of these unusual lesions. 9 Case reports Case 1 JM was diagnosed with pre-B-cell acute lymphocytic leukemia (ALL) at 8 years of age. At presentation, his total peripheral WBC count was 240 000 with 85% circulating blasts. He was initially started on CCG-1961, the high-risk pediatric protocol using a four-drug induction of vincristine, daunorubicin, prednisone, and L-asparaginase. Bone marrow evaluation at the end of induction revealed 425% blasts, consistent with a failure of remission induction. He was subsequently treated with high-dose cytosine arabinoside and L-asparaginase (Capezzi regimen) in preparation for a matched sibling donor BMT. Remission induction was achieved. The preparative regimen for BMT was high-dose cytosine arabinoside and TBI of 1200 cGy for a 6/6 HLA matched sibling transplant. Graft-versus-host disease (GVHD) prophylaxis with shortcourse methotrexate and cyclosporine was administered. He achieved engraftment on day þ 21 (ANC 4500 Â 2 consecutive days) and was stable enough for discharge home on day þ 32. Complications occurring within the first 6 months following the transplant included a severe respiratory illness of probable viral etiology, requiring prolonged intubation, and Grade II skin and gastrointestinal acute GVHD. The acute GVHD required treatment with prednisone at 1 mg/kg/day for 130 days. The patient did not develop any clinically significant chronic graftversus-host disease.
Approximately 28 months post transplant, the patient's mother noticed that his abdomen appeared distended. He had no pain, discomfort, or constitutional symptoms. A CT of the abdomen revealed a 7 cm round solid mass arising from the inferior portion of the right lobe of the liver (Figure 1a and b) . The mass appeared hypervascular with central diffuse enhancement and several faint calcifications. Liver function studies including AST, ALT, PT, APTT, albumin, and bilirubin were all within normal limits for age. The patient underwent right hepatic lobectomy with complete resection of the mass. Upon gross examination in the operating room and by the pathologists (Figure 1c) , the mass appeared fibrotic and was suggestive of a highly aggressive malignant lesion such as an embryonal sarcoma. Microscopic evaluation of the lesion revealed a myxoid background with moderate cellularity (Figure 1d and e). The cells comprising the mass included large spindle cells with a low nuclear :cytoplasmic ratio, nuclear pleomorphism, acute and chronic inflammatory cells with plasma cells most prevalent, and medium-sized fibroblastic-type cells. Surgical margins were clear. The tumor stained positive for smooth muscle actin and Alk-1 protein suggesting the diagnosis of an inflammatory myofibroblastic tumor. It was negative for desmin and EBV latent membrane protein. In situ hybridization for EBV was also negative. Ploidy studies demonstrated diploid chromosome content. Follow-up imaging studies have been negative for recurrence, and JM remains in good clinical condition 7 months postoperatively.
Case 2
BC was diagnosed at age 3 years with Stage IV neuroblastoma, originating within the left adrenal gland, when he presented with weight loss and a refusal to walk. He was initially treated with chemotherapy using CCG 3891 that included cisplatin, etoposide, adriamycin, and cyclophosphamide, in addition to radiation therapy of 1200 cGy to his abdomen. At 6 months after diagnosis, he was admitted for an autologous peripheral stem cell transplant with an unmanipulated stem cell product. His preparative regimen included carboplatin, etoposide, melphalan, and TBI of 1000 cGy. He engrafted by day þ 12, and was stable enough for discharge on day þ 25.
Approximately 2 years after transplant, BC presented with a complaint of difficulty swallowing solid foods. An upper gastrointestinal (UGI) radiograph revealed a stricture in the distal third of his esophagus that was thought related to his radiation therapy. No reflux was noted at that time. He underwent balloon dilatation with subsequent improvement of the focal stricture and clinical symptoms. A followup esophagram was performed approximately 4 months after initial dilatation, revealing a fixed ovoid smooth fillingdefect (Figure 2a ) within the esophagus, just below the carina, most consistent radiographically with an esophageal duplication cyst. The patient was taken for surgical resection in addition to esophageal and stomach biopsies.
On pathological evaluation, the suspected 'duplication cyst' was histologically composed of fibromuscular tissue lined by unremarkable stratified squamous epithelium. The muscular layer was disrupted by a fibrous proliferation with areas composed of fascicles of spindle-shaped cells and other areas of loose myxoid stroma (Figure 2b ). There were variable concentrations of lymphocytes, plasma cells, eosinophils, and histiocytes. The microscopic appearance was typical of an inflammatory pseudotumor. This tumor was negative for EBV. Cytogenetic analysis was not performed. Stomach and esophageal biopsies were negative with the exception of the distal esophagus appearing pathologically like gastric mucosa with signs of chronic inflammation. The stomach biopsy was also negative for bacterial organisms on staining and culture. The patient currently remains in good clinical condition, is on no medications, is without swallowing difficulties, and without evidence of recurrence of pseudotumor.
Discussion
These two cases exemplify previously unreported diagnoses of inflammatory myofibroblastic tumors following hematopoietic stem cell transplantation. Both of these patients underwent intensive chemotherapy regimens that eventually prepared them for transplant, and both were treated with intensive radiation therapy. Chemotherapy is a potential predisposing factor in the development of pseudotumors, as implied by those cases documented after treatment of a variety of malignancies, including leukemia, Wilms tumor, and carcinomas. 1, 3, 6 Most recently, Tan et al 10 described a case of a primary breast carcinoma that was replaced by a pseudotumor following treatment with four courses of adriamycin and cyclophosphamide.
Radiation has long been implicated as contributing to genomic instability, and the development of sarcomas and carcinomas postradiation has been well documented. A recent publication by Oota et al 9 evaluated 2719 patients with squamous cell carcinoma of the oral cavity who were treated with radiation therapy. In their study, 0.22% of patients developed polypoid tumors of the oral cavity that were pathologically diagnosed as pseudotumors. The mean latency period to the formation of the tumors was approximately 79 months. This is much shorter than the latency period typically seen with the development of secondary sarcomas and carcinomas, most often within the range of 8-10 years postradiation. 9 The development of pseudotumors in a population of cancer patients treated solely with radiation suggests that radiation can contribute to the development of these tumors. However, the rate of pseudotumor formation in this set of patients was very low, suggesting other possible predisposing factors.
The two patients described here are unique because their pseudotumors occurred within 24 months following hematopoietic stem cell transplant. Given that infection has been linked to pseudotumor formation, one consideration following transplant is the timing and effectiveness of immune reconstitution. A study by Fujimaki et al 11 attempted to assess immune reconstitution postallogeneic transplant in 91 adult patients. CD4 þ cells and CD4 þ CD45RA þ T were reported as below normal range until 5 years after transplant. There was also evidence in this study that IgA levels do not return to normal until 1-3 years post transplant. 11 Sugita et al 12 showed that subsets of T cells, including CD4 þ CD45RA þ , CD4 þ CD29 þ , and CD4 þ 31 þ cells, were significantly decreased during the first 24 months after both allogeneic and autologous T-celldepleted transplants. In a study of adult and pediatric patients, Shenoy et al 13 found that engraftment of CD4 þ , natural killer, and B cells remains low, and T-cell proliferation remains impaired within the first year after allogeneic peripheral stem transplants. Reconstitution after autologous stem cell transplant has been less well studied, but diminished numbers of CD4 þ cells have been documented for at least 12 months post transplant.
14 Given that all of these studies, independently, provide evidence of a delay in immune system recovery after a variety of hematopoietic stem cell subtypes, it is relevant to ask the question whether a dysfunctional immune system may also predispose to the development of pseudotumors. In the patients discussed in our report, immunoglobulin levels were measured within 3 months of the diagnosis of the pseudotumors. These were normal, suggesting that the Bcell function was likely intact.
In summary, the two cases we describe here support prior observations that multiple predisposing factors, including preceding malignancy, radiation, chemotherapy, and infection, can result in the formation of a pseudotumor. We also propose that it may be reasonable to evaluate the function of the immune system in patients who develop pseudotumors, particularly in the setting of a stem cell transplant. Such an evaluation might include quantitative and qualitative studies of T-cell, natural killer cell, B-cell function, and immunoglobulin levels. It is still possible that both of our cases could have developed spontaneously as there have been case reports of pseudotumors, especially in infants, with no clinically evident underlying conditions. 3, 5 Importantly, careful documentation and histological evaluation of unusual masses with consideration of IMT in children and adults following hematopoietic stem cell transplant and radiation therapy is critical to the appropriate management of these cases, which primarily includes surgical excision and close clinical and radiological followup.
